Splice variants as cancer biomarkers - PubMed (original) (raw)
Review
Splice variants as cancer biomarkers
Brigitta M N Brinkman. Clin Biochem. 2004 Jul.
Abstract
Inherited and acquired changes in pre-mRNA splicing have been documented to play a significant role in human disease development and many cancer-associated genes are regulated by alternative splicing. Loss of fidelity, variation of the splicing process, even controlled switching to specific splicing alternatives may occur during tumor progression and could play a major role in carcinogenesis. Splice variants that are found predominantly in tumors have clear diagnostic value and may provide potential drug targets. Moreover, understanding the process of aberrant splicing and the detailed characterization of the splice variants may prove crucial to our understanding of malignant transformation. This review discusses the basic mechanism of alternative splicing, alternative splicing in cancer-associated genes, tools to identify splice variants, and the development of clinical tests based on alternatively spliced biomarkers.
Similar articles
- Alterations of pre-mRNA splicing in cancer.
Kalnina Z, Zayakin P, Silina K, Linē A. Kalnina Z, et al. Genes Chromosomes Cancer. 2005 Apr;42(4):342-57. doi: 10.1002/gcc.20156. Genes Chromosomes Cancer. 2005. PMID: 15648050 Review. - Alternative splicing in cancer: noise, functional, or systematic?
Skotheim RI, Nees M. Skotheim RI, et al. Int J Biochem Cell Biol. 2007;39(7-8):1432-49. doi: 10.1016/j.biocel.2007.02.016. Epub 2007 Mar 1. Int J Biochem Cell Biol. 2007. PMID: 17416541 Review. - Aberrant and alternative splicing in cancer.
Venables JP. Venables JP. Cancer Res. 2004 Nov 1;64(21):7647-54. doi: 10.1158/0008-5472.CAN-04-1910. Cancer Res. 2004. PMID: 15520162 Review. - [Pre-mRNA alternative splicing in cancer: functional impact, molecular mechanisms and therapeutic perspectives].
Revil T, Shkreta L, Chabot B. Revil T, et al. Bull Cancer. 2006 Sep;93(9):909-19. Bull Cancer. 2006. PMID: 16980234 Review. French. - The connection between splicing and cancer.
Srebrow A, Kornblihtt AR. Srebrow A, et al. J Cell Sci. 2006 Jul 1;119(Pt 13):2635-41. doi: 10.1242/jcs.03053. J Cell Sci. 2006. PMID: 16787944 Review.
Cited by
- Direct isolation and RNA-seq reveal environment-dependent properties of engrafted neural stem/progenitor cells.
Kumamaru H, Ohkawa Y, Saiwai H, Yamada H, Kubota K, Kobayakawa K, Akashi K, Okano H, Iwamoto Y, Okada S. Kumamaru H, et al. Nat Commun. 2012;3:1140. doi: 10.1038/ncomms2132. Nat Commun. 2012. PMID: 23072808 - Alternative splicing and its impact as a cancer diagnostic marker.
Kim YJ, Kim HS. Kim YJ, et al. Genomics Inform. 2012 Jun;10(2):74-80. doi: 10.5808/GI.2012.10.2.74. Epub 2012 Jun 30. Genomics Inform. 2012. PMID: 23105933 Free PMC article. - MDS shows a higher expression of hTERT and alternative splice variants in unactivated T-cells.
Dong W, Wu L, Sun H, Ren X, Epling-Burnette PK, Yang L. Dong W, et al. Oncotarget. 2016 Nov 1;7(44):71904-71914. doi: 10.18632/oncotarget.12115. Oncotarget. 2016. PMID: 27655690 Free PMC article. - An interactive network of alternative splicing events with prognostic value in geriatric lung adenocarcinoma via the regulation of splicing factors.
Wang Y, Wang Y, Li K, Du Y, Cui K, Yu P, Zhang T, Liu H, Ma W. Wang Y, et al. Biosci Rep. 2020 Oct 30;40(10):BSR20202338. doi: 10.1042/BSR20202338. Biosci Rep. 2020. PMID: 33000861 Free PMC article. - Quantitative analysis of FJ 194940.1 gene expression in colon cancer and its association with clinicopathological parameters.
Bartczak-Tomczyk M, Sałagacka A, Mirowski M, Jeleń A, Balcerczak E. Bartczak-Tomczyk M, et al. Contemp Oncol (Pozn). 2013;17(1):45-50. doi: 10.5114/wo.2013.33773. Epub 2013 Mar 15. Contemp Oncol (Pozn). 2013. PMID: 23788961 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources